CNRS UPR9073 Associated with Université Paris Diderot, Sorbonne Paris Cité, Institut de Biologie Physico-chimique (IBPC) 13 rue Pierre et Marie Curie, 75005 Paris, France.
Biochimie. 2012 Jul;94(7):1560-71. doi: 10.1016/j.biochi.2011.12.021. Epub 2012 Jan 2.
Nonsense-mediated mRNA decay (NMD) is a surveillance mechanism that accelerates the degradation of mRNAs containing premature translation termination codons. This quality control pathway depends on the NMD-specific factors, Upf1p, Upf2p/Nmd2p, and Upf3p, as well as the two release factors, eRF1 and eRF3 (respectively designated Sup45p and Sup35p in yeast). NMD activation is also enabled by the absence of the poly(A)-binding protein, Pab1p, downstream of a termination event. Since Sup35p interacts with both Upf1p and Pab1p we considered the possibility that differential binding of the latter factors to Sup35p may be a critical determinant of NMD sensitivity for an mRNA. Here we describe three approaches to assess this hypothesis. First, we tethered fragments or mutant forms of Sup35p downstream of a premature termination codon in a mini-pgk1 nonsense-containing mRNA and showed that the inhibition of NMD by tethered Sup35p does not depend on the domain necessary for the recruitment of Pab1p. Second, we examined the Sup35p interaction properties of Upf1p and Pab1p in vitro and showed that these two proteins bind differentially to Sup35p. Finally, we examined competitive binding between the three proteins and observed that Upf1p inhibits Pab1p binding to Sup35p whereas the interaction between Upf1p and Sup35p is relatively unaffected by Pab1p. These data indicate that the binding of Upf1p and Pab1p to Sup35p may be more complex than anticipated and that NMD activation could involve more than just simple competition between these factors. We conclude that activation of NMD at a premature termination codon is not solely based on the absence of Pab1p and suggest that a specific recruitment step must commit Upf1p to the process and Upf1p-associated mRNAs to NMD.
无义介导的 mRNA 降解(NMD)是一种监控机制,可加速含有过早翻译终止密码子的 mRNA 的降解。这个质量控制途径依赖于 NMD 特异性因子,Upf1p、Upf2p/Nmd2p 和 Upf3p,以及两个释放因子,eRF1 和 eRF3(分别在酵母中指定为 Sup45p 和 Sup35p)。在终止事件下游不存在聚(A)结合蛋白 Pab1p 时,NMD 也被激活。由于 Sup35p 与 Upf1p 和 Pab1p 都相互作用,我们考虑了后者因素对 Sup35p 的差异结合可能是 mRNA NMD 敏感性的关键决定因素。在这里,我们描述了三种方法来评估这一假设。首先,我们在一个 mini-pgk1 无意义包含的 mRNA 中,将 Sup35p 的片段或突变形式连接到过早的终止密码子下游,并表明通过连接的 Sup35p 抑制 NMD 不依赖于招募 Pab1p 所需的结构域。其次,我们在体外研究了 Upf1p 和 Pab1p 与 Sup35p 的相互作用特性,并表明这两种蛋白对 Sup35p 的结合存在差异。最后,我们观察了这三种蛋白质之间的竞争性结合,并发现 Upf1p 抑制 Pab1p 与 Sup35p 的结合,而 Upf1p 与 Sup35p 的相互作用相对不受 Pab1p 的影响。这些数据表明,Upf1p 和 Pab1p 与 Sup35p 的结合可能比预期的更复杂,并且 NMD 的激活可能不仅仅涉及这些因子之间的简单竞争。我们得出结论,在过早的终止密码子处激活 NMD 不仅仅基于 Pab1p 的缺失,并且建议特定的募集步骤必须使 Upf1p 参与该过程,并且使 Upf1p 相关的 mRNA 参与 NMD。